Jia (Jenny) Liu, Translational Lead of Early Phase Drug Development at The Kinghorn Cancer Centre, shared a post on LinkedIn:
“Clinical Trial abstract submissions are open for American Association for Cancer Research Annual Meeting 2026.
For colleagues working in early-phase, translational, or biomarker-driven oncology, this is an important forum to share results from first-in-human, dose-expansion clinical trials and innovative trial designs.
As a member of the AACR Clinical Trials Committee, I encourage investigators and sponsors to review the guidelines and key dates here:
Submission deadline: 12 January 2026 (11:59 pm EST)”
More posts featuring Jia (Jenny) Liu.